Invivyd, Inc., together with its subsidiaries, engages in the research, development, commercialization, and sale of antibody therapies for the prevention and treatment of viral infectious diseases in the United States. The company offers Pemivibart, a half-life extended investigational monoclonal an... Invivyd, Inc., together with its subsidiaries, engages in the research, development, commercialization, and sale of antibody therapies for the prevention and treatment of viral infectious diseases in the United States. The company offers Pemivibart, a half-life extended investigational monoclonal antibody for the pre-exposure prophylaxis prevention of COVID-19 in adults and adolescents through injection under the PEMGARDA brand. It also develops VYD2311, a monoclonal antibody, which is in Phase III clinical trial for the prevention and treatment of SARS-CoV-2 virus; and VBY329, a monoclonal antibody, which is in pre-clinical trial stage for the prevention and treatment of respiratory syncytial virus and measles in neonates, infants, and children. It has a collaboration agreement with Adimab, LLC for the discovery and optimization of proprietary antibodies. The company was formerly known as Adagio Therapeutics, Inc. and changed its name to Invivyd, Inc. in September 2022. Invivyd, Inc. was incorporated in 2020 and is headquartered in New Haven, Connecticut. 詳細を表示
| 期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.154 | -14.9514563107 | 1.03 | 1.07 | 0.7282 | 7092640 | 0.85841945 | CS |
| 4 | -0.334 | -27.6033057851 | 1.21 | 1.25 | 0.7282 | 4080079 | 0.99291537 | CS |
| 12 | -0.504 | -36.5217391304 | 1.38 | 1.8 | 0.7282 | 3447007 | 1.29313275 | CS |
| 26 | -1.474 | -62.7234042553 | 2.35 | 3.01 | 0.7282 | 3194255 | 1.69660908 | CS |
| 52 | 0.086 | 10.8860759494 | 0.79 | 3.0699 | 0.483 | 4690500 | 1.63863521 | CS |
| 156 | -0.394 | -31.0236220472 | 1.27 | 5.195 | 0.3546 | 3301615 | 1.56609778 | CS |
| 260 | -3.824 | -81.3617021277 | 4.7 | 5.195 | 0.3546 | 2685054 | 1.58045732 | CS |
tw0122
7月前
tw0122
7月前
tw0122
7月前
tw0122
7月前
tw0122
7月前
tw0122
7月前
tw0122
8月前
BurgerKing82
8月前
tw0122
10月前
tw0122
10月前
eur06
12月前
dinogreeves
12月前
eur06
12月前
eur06
1年前
dinogreeves
1年前
eur06
1年前
dinogreeves
1年前
dinogreeves
1年前
eur06
1年前
eur06
1年前
dinogreeves
1年前
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
すでにアカウントをお持ちですか? サインイン
アカウントをお持ちでないですか? 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。